Gyre Therapeutics (GYRE)'s 30-day implied volatility (IV30) was 69.8% at the close on November 6, 2026, up from 69.4% the day before, against a 52-week range of 35.3% to 84.4%. Its 20-day historical volatility was 80.4%.
Key numbers
30-day implied volatility (IV30): 69.8%
IV30 52-week range: 35.3% to 84.4% (median 56.2%)
Historical volatility: 20-day 80.4%, 1-year 58.0%
Implied move by the nearest expiration: ±4.4%
Data as of November 6, 2026.
GYRE Implied Volatility (IV) vs Historical Volatility (HV)
The GYRE IV term structure shows the implied volatility difference between different maturity dates.
